Sickle cell anemia is an autosomal recessive disease caused by a mutation in the gene controlling the beta chain of hemoglobin. This mutation replaces glutamic acid with valine at the sixth position of the beta chain. Heterozygous carriers appear unaffected but have a 50% chance of passing on the mutant gene, while homozygous individuals experience symptoms like swelling, anemia, jaundice, stunted growth, and vision problems. Treatment includes medications, blood transfusions, and sometimes bone marrow transplants.